Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

64.06
-0.1914-0.30%
Volume:995
Turnover:63.73K
Market Cap:9.61M
PE:- -
High:64.06
Open:64.06
Low:64.06
Close:64.25
52wk High:64.56
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:6.88
T/O Rate:0.66%
Dividend:0.51
Dividend Rate:0.80%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

UnitedHealth Group (UNH) Joins Zacks Strong Buy List As Undervalued Narrative Builds

Simply Wall St.
·
Aug 23

Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

TIPRANKS
·
Aug 22

Merck & Company Soars on Breakthrough Cancer Vaccine Hopes

TIPRANKS
·
Aug 22

Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 22

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

TIPRANKS
·
Aug 22

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Dow Jones
·
Aug 22

Top Stock Market Highlights of the Week: Sembcorp Industries, Singapore’s Big Three Banks, Moderna and CapitaLand Investment

The Smart Investor
·
Aug 22

Soon You Can Buy Medicare Advantage Plans at Costco. What You Need to Know.

Dow Jones
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Aug 22

Stocks Ex-Dividend August 25

Dow Jones
·
Aug 22

Goldman Sachs, Merck Share Gains Contribute to Dow's 500-Point Jump

Dow Jones
·
Aug 22

US Equity Indexes Lower This Week as Trump Threatens Major Economic War on Iran

MT Newswires Live
·
Aug 22

Merck Price Target Raised to $160.00/Share from $140.00 by Goldman Sachs

Dow Jones
·
Aug 22

UnitedHealth Group (UNH) Stock Looks Cheap On Value But Faces Risk On News

Simply Wall St.
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22